Sensus Healthcare (SRTS) EBIT Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Sensus Healthcare | 47.41 Mn | 29.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.56% |
| Sep 30, 2025 | -271.84% |
| Jun 30, 2025 | -198.03% |
| Mar 31, 2025 | -191.65% |
| Dec 31, 2024 | -180.13% |
| Sep 30, 2024 | 178.89% |
| Jun 30, 2024 | 275.87% |
| Mar 31, 2024 | 198.23% |
| Dec 31, 2023 | 33.68% |
| Sep 30, 2023 | -187.69% |
| Jun 30, 2023 | -124.66% |
| Mar 31, 2023 | -174.78% |
| Dec 31, 2022 | -21.56% |
| Sep 30, 2022 | 1,008.21% |
| Jun 30, 2022 | 1,737.99% |
| Mar 31, 2022 | 452.47% |
| Dec 31, 2021 | 1,969.65% |
| Sep 30, 2021 | 108.56% |
| Jun 30, 2021 | 89.16% |
| Mar 31, 2021 | 69.34% |
| Dec 31, 2020 | -73.89% |
| Sep 30, 2020 | -183.06% |
| Jun 30, 2020 | -5,759.26% |
| Mar 31, 2020 | -65.84% |
| Dec 31, 2019 | 3,049.74% |
| Sep 30, 2019 | -90.18% |
| Jun 30, 2019 | 109.12% |
| Mar 31, 2019 | -96.77% |
| Dec 31, 2018 | 107.82% |
| Sep 30, 2018 | 56.15% |
| Jun 30, 2018 | 34.88% |
| Mar 31, 2018 | 29.83% |
| Jun 30, 2017 | -119.58% |